Abstract: A keel punch impactor comprises a main body having an interior bore. A locking shaft is positioned in the interior bore of the main body, the locking shaft defining a shaft axis. An actuator is in contact with the locking shaft. The actuator is moveable between a first position and a second position. The position of the locking shaft is moved within the interior bore of the main body upon movement of the actuator. In particular, the locking shaft is moved such that the shaft axis is offset when the actuator is moved from the first position to the second position. When the shaft is moved, a head on the shaft is moved into or out of alignment with a boss extending from the main body of the keel punch impactor.

Abstract: Physically and chemically stable, water-soluble, amphiphilic polymer-PDGF complex, characterized in that the amphiphilic polymers include a hydrophilic polymeric backbone functionalized with hydrophobic substituents and hydrophilic groups.

Abstract: Physically and chemically stable, water-soluble, amphiphilic polymer-PDGF complex, characterized in that the amphiphilic polymers include a hydrophilic polymeric backbone functionalized with hydrophobic substituents and hydrophilic groups.

Abstract: Disclosed is a method of minimizing clock uncertainty using a multi-level de-skewing technique. The method includes the steps of obtaining a chip wherein at least a portion of the chip has a regular array of buffers on multiple levels, the buffers being driven by first drivers and the first drivers being driven by second drivers; grouping the buffers in a first direction to create clusters with the same number of buffer inputs, wherein if there are not the same number of buffer inputs in each cluster, then adding dummy buffers to the cluster with a deficient number of buffer inputs; wiring outputs of the first drivers together in a second direction, wherein the first and second directions are orthogonal; and wiring outputs of the second together in the second direction.

Abstract: A keel punch impactor comprises a main body having an interior bore. A locking shaft is positioned in the interior bore of the main body, the locking shaft defining a shaft axis. An actuator is in contact with the locking shaft. The actuator is moveable between a first position and a second position. The position of the locking shaft is moved within the interior bore of the main body upon movement of the actuator. In particular, the locking shaft is moved such that the shaft axis is offset when the actuator is moved from the first position to the second position. When the shaft is moved, a head on the shaft is moved into or out of alignment with a boss extending from the main body of the keel punch impactor.

Abstract: Disclosed is a method of minimizing clock uncertainty using a multi-level de-skewing technique. The method includes the steps of obtaining a chip wherein at least a portion of the chip has a regular array of buffers on multiple levels, the buffers being driven by first drivers and the first drivers being driven by second drivers; grouping the buffers in a first direction to create clusters with the same number of buffer inputs, wherein if there are not the same number of buffer inputs in each cluster, then adding dummy buffers to the cluster with a deficient number of buffer inputs; wiring outputs of the first drivers together in a second direction, wherein the first and second directions are orthogonal; and wiring outputs of the second together in the second direction.

Abstract: Physically and chemically stable, water-soluble, amphiphilic polymer-PDGF complex, characterized in that the amphiphilic polymers include a hydrophilic polymeric backbone functionalized with hydrophobic substituents and hydrophilic groups.

Abstract: Pharmaceutical composition with healing activity comprising at least one soluble dextran derivative and at least one platelet-derived growth factor. The present invention relates to a pharmaceutical composition with healing activity comprising at least one soluble dextran derivative and at least one platelet-derived growth factor, and also to the use thereof for the preparation of a medicament with healing action, in particular for use in the treatment of ulcers.

Abstract: The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising, (1) at least a dextran derivative of general formula DMCaBbSuc, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a?0.6, b=0 or ?0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a?0.3, b?0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.

Abstract: The invention concerns a biologically active material essentially comprising at least an insolubilized dextran derivative of general formula DMCaBbSUcSd and at least a growth factor having an activity on osteoarticular, dental and/or maxillofacial tissues, and the method for preparing same. The invention also concerns the uses of said biomaterial for preparing a repair or filing material, such as an implant, for osteoarticular, dental or maxillofacial applications and for preparing an orthopaedic, dental or maxillofacial prosthesis, and the prosthesis coated with said biologically active material.

Abstract: A threaded fastener holder holds a screw in place and then automatically disengages from the screw and withdraws axially in the proximal direction to permit the user to continue inserting the screw without interruption. The threaded fastener holder has a shaft having a distal end for selectively engaging with a head of a threaded fastener. An inner sleeve surrounds at least a portion of the shaft, and is axially movable with respect to the shaft. The inner sleeve has a plurality of spring fingers disposed at its distal end, each of which has a distal end that is radially movable so as to be selectively engageable with the head of the threaded fastener. A first end of a spring is fixed with respect to the inner sleeve. The second end of the spring is fixed with respect to the shaft. In the rest position, the distal end of the plurality of spring fingers is axially spaced from the distal end of the shaft.

Abstract: The invention concerns dextran derivatives, their applications as medicines with specific biological action, and their preparation method. Said derivatives correspond to the general formula DMCaBbSUcSd, in which: D represents a polysaccharide chain, preferably consisting of sequences of glucoside units, MC represents methylcarboxylate groups, B represents carboxymethylbenzylamide groups, Su represents sulphate groups, S represents sulphonate groups, a, b, c and d represent the degree of substitution (ds), respectively in groups, MC, B, Su and S; a being equal to 0 or ≧0.3, b being equal to 0 or ≧0.1, c being equal to 0 or ≧0.1 and d being equal to 0 or ≧0.

Abstract: The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising. (1) at least a dextran derivative of general formula DMCaBbSuc, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a ≧0.6, b=0 or ≧0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a≧0.3, b ≧0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.

Abstract: The invention concerns a biologically active material essentially comprising at least an insolubilised dextran derivative of general formula DMCaBbSUcSd and at least a growth factor having an activity on osteoarticular, dental and/or maxillofacial tissues, and the method for preparing same. The invention also concerns the uses of said biomaterial for preparing a repair or filing material, such as an implant, for osteoarticular, dental or maxillofacial applications and for preparing an orthopaedic, dental or maxillofacial prosthesis, and the prosthesis coated with said biologically active material.